Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Liver steatosis is a major predictor of poor outcomes in chronic hepatitis C patients with sustained virologic response.

Peleg N, Issachar A, Sneh-Arbib O, Cohen-Naftaly M, Harif Y, Oxtrud E, Braun M, Leshno M, Barsheshet A, Shlomai A.

J Viral Hepat. 2019 Jun 27. doi: 10.1111/jvh.13167. [Epub ahead of print]

PMID:
31243878
2.

25-Hydroxyvitamin D Inhibits Hepatitis C Virus Production in Hepatocellular Carcinoma Cell Line by a Vitamin D Receptor-Independent Mechanism.

Ravid A, Rapaport N, Issachar A, Erman A, Bachmetov L, Tur-Kaspa R, Zemel R.

Int J Mol Sci. 2019 May 13;20(9). pii: E2367. doi: 10.3390/ijms20092367.

3.

The impact of preexisting and posttransplant diabetes mellitus on outcomes following liver transplantation.

Aravinthan AD, Fateen W, Doyle AC, Venkatachalapathy SV, Issachar A, Galvin Z, Sapisochin G, Cattral MS, Ghanekar A, McGilvray ID, Selzner M, Grant DR, Selzner N, Lilly LB, Renner EL, Bhat M.

Transplantation. 2019 Apr 10. doi: 10.1097/TP.0000000000002757. [Epub ahead of print]

PMID:
30985734
4.

Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.

Doyle A, Gorgen A, Muaddi H, Aravinthan AD, Issachar A, Mironov O, Zhang W, Kachura J, Beecroft R, Cleary SP, Ghanekar A, Greig PD, McGilvray ID, Selzner M, Cattral MS, Grant DR, Lilly LB, Selzner N, Renner EL, Sherman M, Sapisochin G.

J Hepatol. 2019 May;70(5):866-873. doi: 10.1016/j.jhep.2018.12.027. Epub 2019 Jan 5.

PMID:
30615906
5.

Transplantation of Livers from Old Donors: Pushing the Envelope Beyond the Seventh Decade.

Nesher E, Braun M, Eizner S, Issachar A, Cohen M, Shlomai A, Gurevich M, Tur-Kaspa R, Mor E.

Isr Med Assoc J. 2018 Dec;20(12):765-769.

6.

Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease.

Peleg N, Sneh Arbib O, Issachar A, Cohen-Naftaly M, Braun M, Shlomai A.

PLoS One. 2018 Aug 14;13(8):e0202393. doi: 10.1371/journal.pone.0202393. eCollection 2018.

7.

The Pattern of Elevated Liver Function Tests in Nonalcoholic Fatty Liver Disease Predicts Fibrosis Stage and Metabolic-Associated Comorbidities.

Shirin D, Peleg N, Sneh-Arbib O, Cohen-Naftaly M, Braun M, Shochat T, Issachar A, Shlomai A.

Dig Dis. 2019;37(1):69-76. doi: 10.1159/000491428. Epub 2018 Jul 17.

PMID:
30016799
8.

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.

Moore A, Cohen-Naftaly M, Tobar A, Kundel Y, Benjaminov O, Braun M, Issachar A, Mor E, Sarfaty M, Bragilovski D, Hur RB, Gordon N, Stemmer SM, Allen AM.

Radiat Oncol. 2017 Oct 19;12(1):163. doi: 10.1186/s13014-017-0899-4.

9.

AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease.

Peleg N, Issachar A, Sneh-Arbib O, Shlomai A.

Dig Liver Dis. 2017 Oct;49(10):1133-1138. doi: 10.1016/j.dld.2017.05.002. Epub 2017 May 11.

PMID:
28572039
10.

Yield of magnetic resonance cholangiopancreatography for the investigation of bile duct dilatation in asymptomatic patients.

Tamir S, Braun M, Issachar A, Bachar GN, Benjaminov O.

United European Gastroenterol J. 2017 Apr;5(3):408-414. doi: 10.1177/2050640616652317. Epub 2016 May 19.

11.

Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma.

Aravinthan AD, Bruni SG, Doyle AC, Thein HH, Goldaracena N, Issachar A, Lilly LB, Selzner N, Bhat M, Sreeharsha B, Selzner M, Ghanekar A, Cattral MS, McGilvray ID, Greig PD, Renner EL, Grant DR, Sapisochin G.

Ann Surg Oncol. 2017 Jul;24(7):1843-1851. doi: 10.1245/s10434-017-5789-3. Epub 2017 Feb 3.

PMID:
28160137
12.

Radiotherapy and Sorafenib in the Management of Patients with Hepatocellular Carcinoma Have Led to Improved Survival: A Single Center Experience.

Moore A, Cohen-Naftaly M, Benjaminov O, Braun M, Issachar A, Mor E, Tovar A, Sarfaty M, Gordon N, Stemmer SM.

J Cancer. 2016 Apr 29;7(8):883-9. doi: 10.7150/jca.14721. eCollection 2016.

13.

The fatty acid-bile acid conjugate Aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease.

Safadi R, Konikoff FM, Mahamid M, Zelber-Sagi S, Halpern M, Gilat T, Oren R; FLORA Group.

Clin Gastroenterol Hepatol. 2014 Dec;12(12):2085-91.e1. doi: 10.1016/j.cgh.2014.04.038. Epub 2014 May 9.

14.

The role of oncogenic viruses in the pathogenesis of hepatocellular carcinoma.

Zemel R, Issachar A, Tur-Kaspa R.

Clin Liver Dis. 2011 May;15(2):261-79, vii-x. doi: 10.1016/j.cld.2011.03.001. Review.

PMID:
21689612
15.

Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.

Shechter M, Issachar A, Marai I, Koren-Morag N, Freinark D, Shahar Y, Shechter A, Feinberg MS.

Int J Cardiol. 2009 May 1;134(1):52-8. doi: 10.1016/j.ijcard.2008.01.021. Epub 2008 May 13.

PMID:
18479768

Supplemental Content

Loading ...
Support Center